Abstract
In 25 U.S. states, healthcare professionals are mandated to report pregnant people for substance use to child protection service (CPS) agencies. This practice is not evidence-based, and we believe it harms the patient-provider relationship, opposes reproductive autonomy, and contributes to racial disparities in CPS referrals and their outcomes. Black patients are more often screened and reported than white patients for prenatal substance use; besides the impact on their obstetric care, this may be a barrier to seeking treatment for substance use disorders. Furthermore, strict, punitive state-level policies are associated with greater odds of neonatal abstinence syndrome. The treatment of substance use disorders in pregnancy under the Child Abuse Prevention and Treatment Act opposes robust evidence understanding substance use disorders as chronic illnesses. Among non-pregnant people seeking healthcare, substance use is not a “reportable offense.” This double marginalization of pregnant patients limits their autonomy and unduly exposes them to the criminal-legal system. Given disparities in prenatal drug screening, Black pregnant patients are at greater risk of such double-jeopardy. Public health and medical organizations have released policy statements against states’ punitive laws, but little has changed. Healthcare providers and institutions should prioritize evidence-based care to benefit the health and wellbeing of birthing person and their infant and combat “legal” interference at the clinic and public-health scale.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
ACOG Committee on Obstetric Practice American Society of Addiction Medicine. (2017). Opioid use and opioid use disorder in pregnancy committee on obstetric practice american society of addiction medicine. Washington, DC: ACOG. http://www.integration.samhsa.gov/. Accessed 21 June 2020.
American Congress of Obstetricians and Gynecologists. (n.d.). Toolkit on state legislation: Pregnant women and prescription drug abuse, dependence and addiction. Washington, DC: American Congress of Obstetricians and Gynecologists. https://www.acog.org/-/media/Departments/Government-Relations-and-Outreach/NASToolkit.pdf. Accessed 21 June 2020.
Atkins, D. N., & Durrance, C. P. (2020). State policies that treat prenatal substance use as child abuse or neglect fail to achieve their intended goals. Health Affairs, 39(5), 756–763. https://doi.org/10.1377/hlthaff.2019.00785.
Bennett, H., Macmillan, A., Jones, R., Blaiklock, A., & McMillan, J. (2020). Should health professionals participate in civil disobedience in response to the climate change health emergency? The Lancet. https://doi.org/10.1016/S0140-6736(19)32985-X.
Bridges, K. M. (2020). RACE, pregnancy, and the opioid epidemic: White privilege and the criminalization of opioid use during pregnancy. Harvard Law Review, 133, 770–851.
Center for Behavioral Health Statistics. (n.d.). Results from the 2012 national survey on drug use and health: Summary of national findings. Rockville: SAMHSA. http://store.samhsa.gov/home. Accessed 21 June 2020.
Child Welfare Information Gateway. (2019). About CAPTA: A legislative history. Washington, DC: Child Welfare Information Gateway. https://www.childwelfare.gov/pubs/factsheets/about/. Accessed 21 June 2020.
Coleman-Cowger, V., Snead, C., & Schulkin, J. (2018). Obstetrician-gynecologists’ referral practices for substance use during pregnancy. Clinical Obstetrics, Gynecology and Reproductive Medicine, 4(4), 1–5. https://doi.org/10.15761/cogrm.1000223.
Crowley, R., Kirschner, N., Dunn, A. S., Bornstein, S. S., Dunn, A., Abraham, G., et al. (2017). Health and public policy to facilitate effective prevention and treatment of substance use disorders involving illicit and prescription drugs: An American College of Physicians position paper. Annals of Internal Medicine, 166(10), 733–736. https://doi.org/10.7326/M16-2953.
Faherty, L. J., Kranz, A. M., Russell-Fritch, J., Patrick, S. W., Cantor, J., & Stein, B. D. (2019). Association of punitive and reporting state policies related to substance use in pregnancy with rates of neonatal abstinence syndrome. JAMA Network Open, 2(11), e1914078. https://doi.org/10.1001/jamanetworkopen.2019.14078.
Goldman-Mellor, S., & Margerison, C. E. (2019). Maternal drug-related death and suicide are leading causes of postpartum death in California. American Journal of Obstetrics and Gynecology, 221(5), 489.e1-489.e9. https://doi.org/10.1016/j.ajog.2019.05.045.
Lloyd Sieger, M. H., & Rebbe, R. (2020). Variation in states’ implementation of CAPTA’s substance-exposed infants mandates: A policy diffusion analysis. Child Maltreatment, 25(4), 457–467. https://doi.org/10.1177/1077559520922313.
Nguemeni Tiako, M. J. (2020). Addressing racial and socioeconomic disparities in access to medications for opioid use disorder amid COVID-19. Journal of Substance Abuse Treatment. https://doi.org/10.1016/j.jsat.2020.108214.
Patrick, S. W., & Schiff, D. M. (2017). A public health response to opioid use in pregnancy. The American Academy Of Pediatrics Pediatrics. https://doi.org/10.1542/peds.2016-4070.
Physicians for Human Rights Establishing sanctuary hospitals: Protecting the right to access health care physicians for human rights fact sheet. (n.d). https://sc.edu/study/colleges_schools/socialwork/documents/bre_grace_new_england_journal_of_me. Accessed 21 June 2020.
Raeside, L. (2003). Attitudes of staff towards mothers affected by substance abuse. British Journal of Nursing, 12(5), 302–310. https://doi.org/10.12968/bjon.2003.12.5.11176.
Roberts, D. E. (1991). Punishing drug addicts who have babies: Women of color, equality, and the right of privacy. Harvard Law Review, 104(7), 1419–1481. https://doi.org/10.2307/1341597.
Roberts, S. C. M., Zahnd, E., Sufrin, C., & Armstrong, M. A. (2015). Does adopting a prenatal substance use protocol reduce racial disparities in CPS reporting related to maternal drug use? A California case study. Journal of Perinatology, 35(2), 146–150. https://doi.org/10.1038/jp.2014.168.
Saitz, R., Larson, M. J., Labelle, C., Richardson, J., & Samet, J. H. (2008). The case for chronic disease management for addiction. Journal of Addiction Medicine. https://doi.org/10.1097/ADM.0b013e318166af74.
Sanmartin, M. X., Ali, M. M., Lynch, S., & Aktas, A. (2020). Association between state-level criminal justice-focused prenatal substance use policies in the US and substance use-related foster care admissions and family reunification. JAMA Pediatrics. https://doi.org/10.1001/jamapediatrics.2020.1027.
Selleck, C. S., & Redding, B. A. (1998). Knowledge and attitudes of registered nurses toward perinatal substance abuse. Journal of Obstetric, Gynecologic, and Neonatal Nursing: JOGNN, 27(1), 70–77. https://doi.org/10.1111/j.1552-6909.1998.tb02593.x.
Simon, R., Snow, R., & Wakeman, S. (2019). Understanding why patients with substance use disorders leave the hospital against medical advice: A qualitative study. Substance Abuse. https://doi.org/10.1080/08897077.2019.1671942.
Stringer, K. L., & Baker, E. H. (2018). Stigma as a barrier to substance abuse treatment among those with unmet need: An analysis of parenthood and marital status. Journal of Family Issues, 39(1), 3–27. https://doi.org/10.1177/0192513X15581659.
Substance Use During Pregnancy|Guttmacher Institute. (n.d.). https://www.guttmacher.org/state-policy/explore/substance-use-during-pregnancy. Accessed 21 June 2020.
Thomas, M., Hutchison, M., Castro, G., Nau, M., Shumway, M., Stotland, N., & Spielvogel, A. (2017). Meeting women where they are: Integration of care as the foundation of treatment for at-risk pregnant and postpartum women. Maternal and Child Health Journal, 21(3), 452–457. https://doi.org/10.1007/s10995-016-2240-5.
Velott, D., Corr, T. E., & Leslie, D. (2019). State policies addressing pregnancy and opioid use disorder. Washington, DC: American Public Health Association. https://apha.confex.com/apha/2019/meetingapp.cgi/Paper/443047. Accessed 3 Nov 2019.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Authors declare that they have no conflict of interest to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Nguemeni Tiako, M.J., Sweeney, L. The Government’s Involvement in Prenatal Drug Testing May Be Toxic. Matern Child Health J 26, 761–763 (2022). https://doi.org/10.1007/s10995-020-03110-2
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10995-020-03110-2